Skip to main content

M EVR7 Pill - white capsule/oblong, 12mm

Pill with imprint M EVR7 is White, Capsule/Oblong and has been identified as Everolimus 7.5 mg. It is supplied by Mylan Pharmaceuticals Inc.

Everolimus is used in the treatment of Neuroendocrine Carcinoma; Breast Cancer; Renal Angiomyolipoma; Organ Transplant, Rejection Prophylaxis; Pancreatic Cancer and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M EVR7

Everolimus 7.5 mg M EVR7

Everolimus

Imprint
M EVR7
Strength
7.5 mg
Color
White
Size
12.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-3098

Get help with Imprint Code FAQs.

Related images for "M EVR7"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.